Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals – A randomized double- blind pre-clinical study

Heba A. Ahmed, Tauheed Ishrat, Bindu Pillai, Kristopher M. Bunting, Ashni Patel, Almira Ivanova Vazdarjanova, Jennifer L Waller, Ali Syed Arbab, Adviye Ergul, Susan C. Fagan

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Growing evidence suggests that renin angiotensin system (RAS) modulators support cognitive function in various animal models. However, little is known about their long-term effects on the brain structure in aged hypertensive animals with chronic cerebral hypoperfusion as well as which specific domains of cognition are most affected. Therefore, in the current study we examined the effects of Candesartan and Compound 21 (C21) (RAS modulators) on aspects of cognition known to diminish with advanced age and accelerate with hypertension and vascular disease. Outcome measures for sensorimotor and cognitive function were performed using a sequence of tests, all blindly conducted and assessed at baseline and after 4 and 8 weeks of chronic hypoxic hypoperfusion and treatment. Magnetic resonance imaging (MRI) was performed at the end of the 8 week study period followed by animal sacrifice and tissue collection. Both Candesartan and C21 effectively preserved cognitive function and prevented progression of vascular cognitive impairment (VCI) but only candesartan prevented loss of brain volume in aged hypertensive animals. Collectively, our findings demonstrate that delayed administration of RAS modulators effectively preserve cognitive function and prevent the development / progression of VCI in aged hypertensive animals with chronic cerebral hypoperfusion.

Original languageEnglish (US)
Pages (from-to)29-40
Number of pages12
JournalBehavioural Brain Research
Volume346
DOIs
StatePublished - Jul 2 2018

Fingerprint

Angiotensins
Cognition
Magnetic Resonance Imaging
Brain
Renin-Angiotensin System
Blood Vessels
Vascular Diseases
Cognitive Dysfunction
Clinical Studies
Animal Models
Outcome Assessment (Health Care)
Hypertension
candesartan

Keywords

  • AT2 Receptor
  • Angiotensin type 1 receptor blockade
  • Hypertension
  • MRI
  • Rat
  • Renin-angiotensin
  • Vascular cognitive impairment

ASJC Scopus subject areas

  • Behavioral Neuroscience

Cite this

Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals – A randomized double- blind pre-clinical study. / Ahmed, Heba A.; Ishrat, Tauheed; Pillai, Bindu; Bunting, Kristopher M.; Patel, Ashni; Vazdarjanova, Almira Ivanova; Waller, Jennifer L; Arbab, Ali Syed; Ergul, Adviye; Fagan, Susan C.

In: Behavioural Brain Research, Vol. 346, 02.07.2018, p. 29-40.

Research output: Contribution to journalArticle

@article{51e9b7502b194af6921def8c139a911e,
title = "Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals – A randomized double- blind pre-clinical study",
abstract = "Growing evidence suggests that renin angiotensin system (RAS) modulators support cognitive function in various animal models. However, little is known about their long-term effects on the brain structure in aged hypertensive animals with chronic cerebral hypoperfusion as well as which specific domains of cognition are most affected. Therefore, in the current study we examined the effects of Candesartan and Compound 21 (C21) (RAS modulators) on aspects of cognition known to diminish with advanced age and accelerate with hypertension and vascular disease. Outcome measures for sensorimotor and cognitive function were performed using a sequence of tests, all blindly conducted and assessed at baseline and after 4 and 8 weeks of chronic hypoxic hypoperfusion and treatment. Magnetic resonance imaging (MRI) was performed at the end of the 8 week study period followed by animal sacrifice and tissue collection. Both Candesartan and C21 effectively preserved cognitive function and prevented progression of vascular cognitive impairment (VCI) but only candesartan prevented loss of brain volume in aged hypertensive animals. Collectively, our findings demonstrate that delayed administration of RAS modulators effectively preserve cognitive function and prevent the development / progression of VCI in aged hypertensive animals with chronic cerebral hypoperfusion.",
keywords = "AT2 Receptor, Angiotensin type 1 receptor blockade, Hypertension, MRI, Rat, Renin-angiotensin, Vascular cognitive impairment",
author = "Ahmed, {Heba A.} and Tauheed Ishrat and Bindu Pillai and Bunting, {Kristopher M.} and Ashni Patel and Vazdarjanova, {Almira Ivanova} and Waller, {Jennifer L} and Arbab, {Ali Syed} and Adviye Ergul and Fagan, {Susan C.}",
year = "2018",
month = "7",
day = "2",
doi = "10.1016/j.bbr.2017.12.007",
language = "English (US)",
volume = "346",
pages = "29--40",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",

}

TY - JOUR

T1 - Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals – A randomized double- blind pre-clinical study

AU - Ahmed, Heba A.

AU - Ishrat, Tauheed

AU - Pillai, Bindu

AU - Bunting, Kristopher M.

AU - Patel, Ashni

AU - Vazdarjanova, Almira Ivanova

AU - Waller, Jennifer L

AU - Arbab, Ali Syed

AU - Ergul, Adviye

AU - Fagan, Susan C.

PY - 2018/7/2

Y1 - 2018/7/2

N2 - Growing evidence suggests that renin angiotensin system (RAS) modulators support cognitive function in various animal models. However, little is known about their long-term effects on the brain structure in aged hypertensive animals with chronic cerebral hypoperfusion as well as which specific domains of cognition are most affected. Therefore, in the current study we examined the effects of Candesartan and Compound 21 (C21) (RAS modulators) on aspects of cognition known to diminish with advanced age and accelerate with hypertension and vascular disease. Outcome measures for sensorimotor and cognitive function were performed using a sequence of tests, all blindly conducted and assessed at baseline and after 4 and 8 weeks of chronic hypoxic hypoperfusion and treatment. Magnetic resonance imaging (MRI) was performed at the end of the 8 week study period followed by animal sacrifice and tissue collection. Both Candesartan and C21 effectively preserved cognitive function and prevented progression of vascular cognitive impairment (VCI) but only candesartan prevented loss of brain volume in aged hypertensive animals. Collectively, our findings demonstrate that delayed administration of RAS modulators effectively preserve cognitive function and prevent the development / progression of VCI in aged hypertensive animals with chronic cerebral hypoperfusion.

AB - Growing evidence suggests that renin angiotensin system (RAS) modulators support cognitive function in various animal models. However, little is known about their long-term effects on the brain structure in aged hypertensive animals with chronic cerebral hypoperfusion as well as which specific domains of cognition are most affected. Therefore, in the current study we examined the effects of Candesartan and Compound 21 (C21) (RAS modulators) on aspects of cognition known to diminish with advanced age and accelerate with hypertension and vascular disease. Outcome measures for sensorimotor and cognitive function were performed using a sequence of tests, all blindly conducted and assessed at baseline and after 4 and 8 weeks of chronic hypoxic hypoperfusion and treatment. Magnetic resonance imaging (MRI) was performed at the end of the 8 week study period followed by animal sacrifice and tissue collection. Both Candesartan and C21 effectively preserved cognitive function and prevented progression of vascular cognitive impairment (VCI) but only candesartan prevented loss of brain volume in aged hypertensive animals. Collectively, our findings demonstrate that delayed administration of RAS modulators effectively preserve cognitive function and prevent the development / progression of VCI in aged hypertensive animals with chronic cerebral hypoperfusion.

KW - AT2 Receptor

KW - Angiotensin type 1 receptor blockade

KW - Hypertension

KW - MRI

KW - Rat

KW - Renin-angiotensin

KW - Vascular cognitive impairment

UR - http://www.scopus.com/inward/record.url?scp=85037723884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037723884&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2017.12.007

DO - 10.1016/j.bbr.2017.12.007

M3 - Article

C2 - 29229547

AN - SCOPUS:85037723884

VL - 346

SP - 29

EP - 40

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

ER -